State of Alaska Department of Revenue’s TG Therapeutics TGTX Stock Holding History

State of Alaska Department of Revenue’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.43M	Sell	62,402 -23,941	-28%	-$980K	0.03%	447
2026 Q1	$2.87M	Sell	86,343 -1,862	-2%	-$55.5K	0.03%	534
2025 Q4	$2.63M	Buy	88,205 +19,932	+29%	+$651K	0.03%	566
2025 Q3	$2.47M	Sell	68,273 -12,510	-15%	-$412K	0.03%	626
2025 Q2	$2.91M	Buy	80,783 +6,827	+9%	+$254K	0.03%	527
2025 Q1	$2.92M	Sell	73,956 -1,900	-3%	-$63.9K	0.03%	504
2024 Q4	$2.28M	Sell	75,856 -274	-0.4%	-$7.86K	0.03%	639
2024 Q3	$1.78M	Buy	+76,130	New	+$1.66M	0.02%	776

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

State of Alaska Department of Revenue's TGTX Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its TG Therapeutics (TGTX) stake by 28% in Q2 2026, selling an estimated $980K and leaving 62,402 shares worth $3.43M. The position accounts for 0.03% of the portfolio, ranked #447.

State of Alaska Department of Revenue first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

State of Alaska Department of Revenue held 62,402 shares of TG Therapeutics worth $3.43M as of Q2 2026.
State of Alaska Department of Revenue sold 23,941 TG Therapeutics shares in Q2 2026, an estimated $980K.
TG Therapeutics made up 0.03% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #447 holding.
State of Alaska Department of Revenue first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.